UBS Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-878,850
| Closed | -$86.5M | – | 10302 |
|
|
2025
Q2 | $86.5M | Buy |
878,850
+244,349
| +39% | +$23.1M | 0.02% | 1073 |
|
|
2025
Q1 | $58.8M | Buy |
634,501
+421,660
| +198% | +$38.9M | 0.01% | 1340 |
|
|
2024
Q4 | $19.3M | Buy |
212,841
+172,527
| +428% | +$15.8M | ﹤0.01% | 2355 |
|
|
2024
Q3 | $3.89M | Sell |
40,314
-22,023
| -35% | -$2.15M | ﹤0.01% | 3337 |
|
|
2024
Q2 | $5.72M | Sell |
62,337
-12,745
| -17% | -$1.18M | ﹤0.01% | 2736 |
|
|
2024
Q1 | $6.92M | Buy |
75,082
+67,097
| +840% | +$6.29M | ﹤0.01% | 2618 |
|
|
2023
Q4 | $759K | Sell |
7,985
-34,316
| -81% | -$3.21M | ﹤0.01% | 4737 |
|
|
2023
Q3 | $3.95M | Buy |
42,301
+32,610
| +336% | +$3.01M | ﹤0.01% | 2804 |
|
|
2023
Q2 | $886K | Sell |
9,691
-9,440
| -49% | -$774K | ﹤0.01% | 4353 |
|
|
2023
Q1 | $1.41M | Buy |
19,131
+1,697
| +10% | +$147K | ﹤0.01% | 3787 |
|
|
2022
Q4 | $1.46M | Sell |
17,434
-38,671
| -69% | -$3.49M | ﹤0.01% | 3704 |
|
|
2022
Q3 | $5.43M | Buy |
56,105
+1,432
| +3% | +$171K | ﹤0.01% | 2283 |
|
|
2022
Q2 | $5.75M | Buy |
54,673
+8,158
| +18% | +$1.04M | ﹤0.01% | 2258 |
|
|
2022
Q1 | $8.01M | Buy |
46,515
+2,431
| +6% | +$363K | ﹤0.01% | 2117 |
|
|
2021
Q4 | $7.14M | Sell |
44,084
-23,145
| -34% | -$3.72M | ﹤0.01% | 2466 |
|
|
2021
Q3 | $10M | Buy |
67,229
+48,622
| +261% | +$10.1M | ﹤0.01% | 2027 |
|
|
2021
Q2 | $4.56M | Buy |
18,607
+2,506
| +16% | +$657K | ﹤0.01% | 2775 |
|
|
2021
Q1 | $4.26M | Sell |
16,101
-1,968
| -11% | -$555K | ﹤0.01% | 2782 |
|
|
2020
Q4 | $5.3M | Buy |
18,069
+1,703
| +10% | +$437K | ﹤0.01% | 2385 |
|
|
2020
Q3 | $3.87M | Sell |
16,366
-117
| -0.7% | -$26.6K | ﹤0.01% | 2437 |
|
|
2020
Q2 | $3.27M | Buy |
16,483
+903
| +6% | +$168K | ﹤0.01% | 2412 |
|
|
2020
Q1 | $2.86M | Sell |
15,580
-30,230
| -66% | -$5.38M | ﹤0.01% | 2414 |
|
|
2019
Q4 | $7.65M | Buy |
45,810
+5,190
| +13% | +$772K | ﹤0.01% | 2191 |
|
|
2019
Q3 | $5.32M | Buy |
40,620
+21,866
| +117% | +$2.85M | ﹤0.01% | 2334 |
|
|
2019
Q2 | $2.28M | Sell |
18,754
-20,851
| -53% | -$2.47M | ﹤0.01% | 3034 |
|
|
2019
Q1 | $4.88M | Buy |
39,605
+5,546
| +16% | +$696K | ﹤0.01% | 2222 |
|
|
2018
Q4 | $3.99M | Buy |
34,059
+9,777
| +40% | +$1.15M | ﹤0.01% | 2363 |
|
|
2018
Q3 | $3.03M | Sell |
24,282
-38,293
| -61% | -$4.23M | ﹤0.01% | 2817 |
|
|
2018
Q2 | $5.35M | Buy |
62,575
+53,952
| +626% | +$3.96M | ﹤0.01% | 2288 |
|
|
2018
Q1 | $520K | Sell |
8,623
-1,970
| -19% | -$112K | ﹤0.01% | 4169 |
|
|
2017
Q4 | $558K | Sell |
10,593
-455
| -4% | -$24K | ﹤0.01% | 4215 |
|
|
2017
Q3 | $618K | Sell |
11,048
-513
| -4% | -$27.1K | ﹤0.01% | 4054 |
|
|
2017
Q2 | $727K | Buy |
11,561
+202
| +2% | +$11.8K | ﹤0.01% | 3854 |
|
|
2017
Q1 | $580K | Buy |
11,359
+1,067
| +10% | +$50.9K | ﹤0.01% | 3937 |
|
|
2016
Q4 | $439K | Sell |
10,292
-496
| -5% | -$21.1K | ﹤0.01% | 4225 |
|
|
2016
Q3 | $511K | Buy |
10,788
+280
| +3% | +$14K | ﹤0.01% | 3914 |
|
|
2016
Q2 | $530K | Sell |
10,508
-165
| -2% | -$8.33K | ﹤0.01% | 3841 |
|
|
2016
Q1 | $516K | Sell |
10,673
-1,905
| -15% | -$73.5K | ﹤0.01% | 3753 |
|
|
2015
Q4 | $495K | Buy |
12,578
+631
| +5% | +$25.2K | ﹤0.01% | 3957 |
|
|
2015
Q3 | $454K | Buy |
11,947
+451
| +4% | +$19K | ﹤0.01% | 3975 |
|
|
2015
Q2 | $457K | Buy |
11,496
+877
| +8% | +$27.3K | ﹤0.01% | 4201 |
|
|
2015
Q1 | $284K | Sell |
10,619
-41,563
| -80% | -$1.17M | ﹤0.01% | 4599 |
|
|
2014
Q4 | $1.53M | Buy |
+52,182
| New | +$1.29M | ﹤0.01% | 3163 |
|
Other funds holding AMED
IA
MCI
HNB